therapeut approach neoplasm aid multifactori etiolog kaposi sarcoma KS men genet predisposit immunosuppress KS associ human immunodefici viru hiv infect product certain growth factor hiv se etiolog role tat gene therapeut option irradi local cosmet control interferon-alpha combin antiretrovir agent interferon-alpha chemotherapi use antineoplast agent combin case advanc diseas success result immunosuppress neutropenia patient infect surviv aids-rel lymphoma late manifest hiv infect widespread extranod diseas median surviv time seri month two-third patient central nervou system involv time cours ill intens chemotherapeut regimen likelihood opportunist infect surviv combin antineoplast agent low dose short period long-term remiss 